173 related articles for article (PubMed ID: 230784)
1. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine.
Klein RJ; Friedman-Kien AE; DeStefano E
Antimicrob Agents Chemother; 1979 May; 15(5):723-9. PubMed ID: 230784
[TBL] [Abstract][Full Text] [Related]
2. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
[TBL] [Abstract][Full Text] [Related]
3. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
Klein RJ; Friedman-Kien AE; Yellin PB
Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
[TBL] [Abstract][Full Text] [Related]
4. Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site.
Klein RJ; Friedman-Kien AE; Brady E
Arch Virol; 1978; 57(2):161-6. PubMed ID: 208489
[TBL] [Abstract][Full Text] [Related]
5. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice.
Field HJ; Bell SE; Elion GB; Nash AA; Wildy P
Antimicrob Agents Chemother; 1979 Apr; 15(4):554-61. PubMed ID: 464587
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
Klein RJ; Friedman-Kien AE; DeStefano E
Infect Immun; 1981 Dec; 34(3):693-701. PubMed ID: 6277789
[TBL] [Abstract][Full Text] [Related]
7. Immune response and latent infection after topical treatment of herpes simplex virus infection in hairless mice.
Klein RJ; Friedman-Kien AE; Fondak AA; Buimovici-Klein E
Infect Immun; 1977 Jun; 16(3):842-8. PubMed ID: 197008
[TBL] [Abstract][Full Text] [Related]
8. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on the acute local phase of herpes simplex virus-induced skin infections in mice and the establishment of latency.
Klein RJ; Friedman-Kien AE
Antimicrob Agents Chemother; 1985 May; 27(5):763-8. PubMed ID: 3874596
[TBL] [Abstract][Full Text] [Related]
9. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
[TBL] [Abstract][Full Text] [Related]
10. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Svennerholm B; Vahlne A; Lycke E
Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
[TBL] [Abstract][Full Text] [Related]
11. Experimental skin infection with an acyclovir resistant herpes simplex virus mutant: response to antiviral treatment and protection against reinfection.
Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
Arch Virol; 1980; 65(3-4):237-46. PubMed ID: 6251784
[TBL] [Abstract][Full Text] [Related]
12. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain.
Klein RJ; Kaley LA; Friedman-Kien AE
Vaccine; 1984 Sep; 2(3):219-23. PubMed ID: 6099650
[TBL] [Abstract][Full Text] [Related]
13. Establishment of latent ganglionic infection with herpes simplex virus via maxillary gingiva and viral re-activation in vivo after trauma.
Shimizu F; Monma Y; Sekizawa T; Kamiyama K
J Dent Res; 1989 Mar; 68(3):472-5. PubMed ID: 2537858
[TBL] [Abstract][Full Text] [Related]
14. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.
Price RW; Walz MA; Wohlenberg C; Notkins AL
Science; 1975 May; 188(4191):938-40. PubMed ID: 166432
[TBL] [Abstract][Full Text] [Related]
15. Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections.
Zweerink HJ; Martinez D; Lynch RJ; Stanton LW
Infect Immun; 1981 Jan; 31(1):267-75. PubMed ID: 6260662
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
Klein RJ
Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of phosphonoacetic acid on herpes simplex virus infection of sensory ganglia.
Wohlenberg CR; Walz MA; Notkins AL
Infect Immun; 1976 May; 13(5):1519-21. PubMed ID: 178609
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
Klein RJ; Buimovici-Klein E; Moser H; Moucha R; Hilfenhaus J
Arch Virol; 1981; 68(2):73-80. PubMed ID: 6264897
[TBL] [Abstract][Full Text] [Related]
19. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
McKendall RR; Klassen T; Baringer JR
Infect Immun; 1979 Feb; 23(2):305-11. PubMed ID: 217828
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
Yamamoto M; Hayashi Y; Tang LL; Mori R
Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
